Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech (human IgG1 monoclonal antibody specific for human interleukin-1 alpha)
- Region
- 🇪🇺 EU
- Active substance
- human IgG1 monoclonal antibody specific for human interleukin-1 alpha
- Company
- XBiotech Germany GmbH
- Status
- Refused
- Therapeutic area
- Colorectal Neoplasms
- CHMP opinion
- Thu 14 Sep 2017
- Application
- EMEA/H/C/004388
- ATC
- L01
- Official record
- www.ema.europa.eu
Indication
Treatment of metastatic colorectal cancer
Regulatory milestones
No milestones recorded in the last year.
Follow Human IGG1 monoclonal antibody specific for human interleukin-1 alpha XBiotech
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.